DRDO's anti-covid drug 2-DG launched; checkout efficacy, price, dosage
Anti-Covid oral drug has been developed by DRDO's leading laboratory -- Institute of Nuclear Medicine and Allied Sciences in collaboration with Dr Reddy's Laboratories
BusinessToday.In | May 17, 2021 | Updated 12:57 IST
Defence minister Rajnath Singh and health minister Harsh Vardhan. Photo Credit: ANI
Union defence minister Rajnath Singh today released the first batch of the anti-Covid-19 drug, 2-deoxy-D-glucose (2-DG), which has been granted emergency approval by the Drug Controller General of India (DCGI). The anti-Covid oral drug has been developed by the Defence Research and Development Organisation's (DRDO's) leading laboratory- Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr Reddy's Laboratories.

Related Keywords

India , Bharat , Sudhir Chandna , Rajnath Singh , Sudhir Chandana , Institute Of Nuclear Medicine , Development Organisation , Defence Research , Drug Controller General , Nuclear Medicine , Allied Sciences , Bharat Biotech , Harsh Vardhan , 2 Dg Drug , Drdo Covid 19 Medicine , Rdo Covid 19 Drug , Drdo Coronavirus Drug , Drdo Coronavirus News , Drdo 2 Dg Covid 18 Drug , How 2 Dg Covid 19 Drg Works , How Drdo Drg Works , How Drdo Drug Developed , இந்தியா , பாரத் , ராஜ்நாத் சிங் , நிறுவனம் ஆஃப் அணு மருந்து , வளர்ச்சி ஆர்கநைஸேஶந் , பாதுகாப்பு ஆராய்ச்சி , மருந்து கட்டுப்படுத்தி ஜநரல் , அணு மருந்து , கூட்டணி அறிவியல் , பாரத் பயோடெக் , கடுமையான வர்தன் ,